Searched for
NAMUSCLA
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analysts- Indian or MNC pharma companies? There are reasons to look at both: 5 pharma stocks with upside potential of up to 38%
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...20 Dec, 2024, 11.03 AM IST
- Trump & Tariffs: Pharma sector might escape the inevitable tariff troubles. 6 pharma stocks, 5 with an upside potential of up to 38%Exactly eight years ago, in 2016, when a reality TV star became US president, the global markets went into sharp decline on the day of surp...07 Nov, 2024, 11.48 AM IST
- In volatile times, defensive stocks or defensive businesses? The two are different. 7 stocks from second category with an upside potential of up to 32%Last Friday was probably the sixth time in 2024 that practically all sectoral indices were in the red. Needless to say, the market breadth ...27 Oct, 2024, 02.10 PM IST
- Lupin inks pact with Celnova Pharma for distribution of drug in 2 South American nationsLupin's subsidiary has signed a pact with Celnova Pharma to distribute NaMuscla in Argentina and Colombia. The drug treats non-dystrophic m...27 Sep, 2024, 09.47 PM IST
- The yen connection: 4 Indian pharma stocks which benefit from the strength of Japanese yen with an upside potential of up to 15%Every event in the currency market has a twin impact, while some lose but there are others which also gain. But given the mayhem on the str...06 Aug, 2024, 03.51 PM IST
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...18 Jun, 2024, 12.48 PM IST
- They just happen to be listed in India, what matters to them is global developments: 5 stocks from two sectors with upside scope of up to 29%In the last month of volatility, there are some sectors which have shown a streak of out performance. They haven't fallen as much as nifty ...01 Jun, 2024, 02.49 PM IST
- Ready for another round of re-rating even in a volatile market? 5 Indian pharma stocks with upside potential of up to 41%In the last two years, every sector has come into focus at one point of time or the other. Some came into limelight due to the fact of real...07 Mar, 2024, 11.52 AM IST
- Business and valuation tailwinds to help in outperformance? 5 Indian pharma stocks with upside potential of up to 32%Just before the whole market was consumed by the PSU rally, one sector that came into the limelight after many years of underperformance wa...18 Feb, 2024, 01.21 PM IST
- Defensive bet with macro tailwinds? 5 Indian pharma stocks with upside potential of up to 20%On Tuesday, when the whole market was reeling under pressure, two stocks reacted to their numbers in a positive direction. Both of them wer...24 Jan, 2024, 02.46 PM IST
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...04 Jan, 2024, 02.09 PM IST
- Stocks in news: TCS, Tata Motors, RIL, IRB Infrastructure, JSW Steel, Sona BLWThe company's subsidiary Jaguar Land Rover saw a 15% YoY rise in wholesale sales volumes to 79,591 units in the December quarter, on the ba...10 Jan, 2023, 07.11 AM IST
- Stocks in the news: Zomato, Tata Steel, Nykaa, ACC, IB Housing and LupinHindalco, M&M, Zomato, Piramal Enterprises, Hero MotoCorp, ABB, Page Industries, HAL, Trent, IRFC, Bharat Forge, MRF and Cummins are among ...10 Feb, 2022, 09.03 AM IST
- Lupin enters pact with Medis to distribute orphan drug in EuropeNDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following vol...09 Feb, 2022, 07.32 PM IST
- Lupin inks distribution pact with 3 firms to commercialise NaMuscla in EuropeExeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adul...03 Jun, 2020, 01.18 PM IST
- Lupin aims to launch new products across geographies this fiscal"Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market," company said.14 Jul, 2019, 12.30 PM IST
- Lupin gets European Commission nod for myotonia treatment drugLupin said it is preparing for the launch of NaMuscla, which will occur in the initial markets of Germany and the UK in the first quarter o...08 Jan, 2019, 01.04 PM IST
Load More
